Charles Harrington

University of Aberdeen

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Vesna Vuksanovic

Senior Lecturer

Swansea University

UNITED KINGDOM

View details

Mohammad Arastoo

University of Aberdeen

UNITED KINGDOM

View details

Alison Murray

University of Aberdeen

UNITED KINGDOM

View details

Karima Schwab

University of Aberdeen

UNITED KINGDOM

View details

Jochen Klein

professor

Goethe University Frankfurt

GERMANY

View details

Lewis Penny

University of Aberdeen

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Charles Harrington

Research Interests

Explore related searches

Contact this professor

Articles (19)

Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer’s disease

Rivastigmine interferes with the pharmacological activity of hydromethylthionine on presynaptic proteins in the line 66 model of frontotemporal dementia

A key region of Tau that is able to drive assembly and modulate inhibition by Hydromethylthionine

Hydromethylthionine sustains truncated tau-dependent inflammation-lowering effects in mouse brain

Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies

LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy

Solubility of α-synuclein species in the L62 mouse model of synucleinopathy

High-affinity antibodies specific to the core region of the tau protein exhibit diagnostic and therapeutic potential for Alzheimer’s disease

Rescue of synaptosomal glutamate release defects in tau transgenic mice by the tau aggregation inhibitor hydromethylthionine

Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model

Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice

Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis

Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants

HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine

Proteomic analysis of hydromethylthionine in the line 66 model of frontotemporal dementia demonstrates actions on tau-dependent and tau-independent networks

Degeneration of basal and limbic networks is a core feature of behavioural variant frontotemporal dementia

Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer’s Disease Brains

Oxidative Stress Conditions Result in Trapping of PHF-Core Tau (297–391) Intermediates

Differential compartmental processing and phosphorylation of pathogenic human tau and native mouse tau in the line 66 model of frontotemporal dementia

Collaborators (6)

Vesna Vuksanovic

Mohammad Arastoo

Alison Murray

Karima Schwab

Jochen Klein

Lewis Penny

Make your next move.